argenx SE (ARGX.BR)

EUR 575.6

(1.34%)

Total Assets Summary of argenx SE

argenx SE's latest annual total assets in 2023 was 4.11 Billion EUR , up 31.2% from previous year.
argenx SE's latest quarterly total assets in 2024 Q2 was 4.79 Billion EUR , down 0.0% from previous quarter.
argenx SE reported annual total assets of 3.13 Billion USD in 2022, up 9.96% from previous year.
argenx SE reported annual total assets of 2.85 Billion USD in 2021, up 24.75% from previous year.
argenx SE reported quarterly total assets of 4.79 Billion EUR for 2024 Q2, down 0.0% from previous quarter.
argenx SE reported quarterly total assets of - USD for 2023 Q3, down -100.0% from previous quarter.

Annual Total Assets Chart of argenx SE (2023 - 2010)

Historical Annual Total Assets of argenx SE (2023 - 2010)

Year	Total Assets	Total Assets Growth
2023	4.11 Billion EUR	31.2%
2022	3.13 Billion USD	9.96%
2021	2.85 Billion USD	24.75%
2020	2.28 Billion EUR	42.31%
2019	1.6 Billion EUR	142.65%
2018	661.69 Million EUR	48.7%
2017	444.97 Million EUR	300.02%
2016	111.24 Million EUR	121.37%
2015	50.25 Million EUR	-29.37%
2014	71.14 Million EUR	105.99%
2013	34.53 Million EUR	50.63%
2012	22.92 Million EUR	-28.21%
2011	31.94 Million EUR	160.5%
2010	12.26 Million EUR	0.0%

Year	Total Assets	Total Assets Growth
2024 Q1	- USD	-100.0%
2024 Q2	4.79 Billion EUR	0.0%
2023 Q3	- USD	-100.0%
2023 Q1	- USD	-100.0%
2023 Q2	3.19 Billion USD	0.0%
2023 FY	4.11 Billion EUR	31.2%
2023 Q4	4.54 Billion USD	0.0%
2022 Q3	- USD	-100.0%
2022 FY	3.13 Billion USD	9.96%
2022 Q2	3.24 Billion USD	0.0%
2022 Q4	3.13 Billion USD	0.0%
2021 Q4	2.85 Billion USD	0.0%
2021 FY	2.85 Billion USD	24.75%
2021 Q2	3.21 Billion USD	0.0%
2020 Q4	2.28 Billion EUR	0.0%
2020 Q2	2.27 Billion EUR	0.0%
2020 FY	2.28 Billion EUR	42.31%
2019 FY	1.6 Billion EUR	142.65%
2019 Q2	1.14 Billion EUR	0.0%
2019 Q4	1.43 Billion EUR	0.0%
2018 Q2	416.25 Million EUR	0.0%
2018 FY	661.69 Million EUR	48.7%
2018 Q4	661.69 Million EUR	0.0%
2017 FY	444.97 Million EUR	300.02%
2017 Q4	444.97 Million EUR	0.0%
2017 Q2	212.18 Million EUR	0.0%
2016 Q2	130.51 Million EUR	0.0%
2016 Q4	111.24 Million EUR	0.0%
2016 FY	111.24 Million EUR	121.37%
2015 FY	50.25 Million EUR	-29.37%
2015 Q2	61.15 Million EUR	0.0%
2015 Q4	50.25 Million EUR	0.0%
2014 Q1	30.99 Million EUR	-10.26%
2014 Q4	71.14 Million EUR	0.0%
2014 Q2	38 Million EUR	22.61%
2014 FY	71.14 Million EUR	105.99%
2013 Q4	34.53 Million EUR	0.0%
2013 FY	34.53 Million EUR	50.63%
2012 FY	22.92 Million EUR	-28.21%
2011 FY	31.94 Million EUR	160.5%
2010 FY	12.26 Million EUR	0.0%

Peer Total Assets Comparison of argenx SE

Name	Total Assets	Total Assets Difference
Nicox S.A.	52.98 Million EUR	-7661.654%
European Medical Solutions	43.75 Million EUR	-9297.423%
FERMENTALG	50.24 Million EUR	-8084.309%
BioSenic S.A.	9.55 Million EUR	-42918.351%
Celyad Oncology SA	16.28 Million EUR	-25155.646%
Hyloris Pharmaceuticals SA	47.68 Million EUR	-8524.241%
Onward Medical N.V.	43.62 Million EUR	-9325.208%
Oxurion NV	6.55 Million EUR	-62680.522%
PHAXIAM Therapeutics S.A.	51.3 Million EUR	-7914.743%
Financière de Tubize SA	1.92 Billion EUR	-114.146%
UCB SA	15.53 Billion EUR	73.537%